---
title: "Vir Biotechnology, Inc. Stock 12‑Month Price Target Raised to $21.56, Implies 161% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289425168.md"
description: "Vir Biotechnology's 12-month average price target was raised to $21.56 by 9 analysts, up from $21.11, implying a 161% upside based on the June 10 closing price. Forecasts range from $16 to $30. The consensus rating remains 'Buy' across all 10 covering analysts."
datetime: "2026-06-11T07:20:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289425168.md)
  - [en](https://longbridge.com/en/news/289425168.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289425168.md)
generator: "portal-rs"
---

# Vir Biotechnology, Inc. Stock 12‑Month Price Target Raised to $21.56, Implies 161% Upside

-   According to estimates from 9 analysts, Vir Biotechnology, Inc. stock's average price target has risen from $21.11 to $21.56, with forecasts ranging from $16 to $30 per share
-   Based on the Jun. 10 closing price, the updated target implies approximately 161% potential upside
-   Consensus rating remains at “Buy” across 10 covering analysts, with 10 Buys, 0 Holds and 0 Sells

Explore more price target data and ratings for Vir Biotechnology, Inc. on the , and track all previous and future analyst recommendations for Vir Biotechnology, Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [VIR.US](https://longbridge.com/en/quote/VIR.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Vir Biotechnology names Brent Sabatini interim principal financial officer as CFO exits](https://longbridge.com/en/news/293757111.md)
- [Analyst Reiterates Buy on Vir Biotechnology, Citing Advancing Hepatitis D and Oncology Pipelines and Strong Cash Runway](https://longbridge.com/en/news/295091535.md)
- [Starfighters Space, Inc. GAAP EPS of -$0.24](https://longbridge.com/en/news/296400745.md)
- [Alphabet Inc. Makes New $9.82 Million Investment in Sana Biotechnology, Inc. $SANA](https://longbridge.com/en/news/296188088.md)
- [Cloudastructure Inc. reports Q2 results](https://longbridge.com/en/news/296127291.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**